Annual Revenue
$1.30 M
-$68.66 M-98.14%
31 December 2023
Summary:
TherapeuticsMD annual revenue is currently $1.30 million, with the most recent change of -$68.66 million (-98.14%) on 31 December 2023. During the last 3 years, it has fallen by -$63.57 million (-97.99%). TXMD annual revenue is now -98.14% below its all-time high of $69.96 million, reached on 31 December 2022.TXMD Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$547.00 K
+$313.00 K+133.76%
30 September 2024
Summary:
TherapeuticsMD quarterly revenue is currently $547.00 thousand, with the most recent change of +$313.00 thousand (+133.76%) on 30 September 2024. Over the past year, it has increased by +$600.00 thousand (+1132.08%). TXMD quarterly revenue is now -99.20% below its all-time high of $68.57 million, reached on 31 December 2022.TXMD Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$1.60 M
+$600.00 K+60.24%
30 September 2024
Summary:
TherapeuticsMD TTM revenue is currently $1.60 million, with the most recent change of +$600.00 thousand (+60.24%) on 30 September 2024. Over the past year, it has dropped by -$67.77 million (-97.70%). TXMD TTM revenue is now -98.24% below its all-time high of $90.85 million, reached on 30 September 2021.TXMD TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TXMD Revenue Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -98.1% | +1132.1% | -97.7% |
3 y3 years | -98.0% | -97.8% | -98.2% |
5 y5 years | -91.9% | -97.7% | -95.9% |
TXMD Revenue High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -98.1% | at low | -99.2% | +100.8% | -98.2% | +102.5% |
5 y | 5 years | -98.1% | at low | -99.2% | +100.8% | -98.2% | +102.5% |
alltime | all time | -98.1% | >+9999.0% | -99.2% | +100.8% | -98.2% | +102.5% |
TherapeuticsMD Revenue History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $547.00 K(+133.8%) | $1.60 M(+60.2%) |
June 2024 | - | $234.00 K(-25.2%) | $996.00 K(-16.9%) |
Mar 2024 | - | $313.00 K(-37.6%) | $1.20 M(-7.9%) |
Dec 2023 | $1.30 M(-98.1%) | $502.00 K(-1047.2%) | $1.30 M(-98.1%) |
Sept 2023 | - | -$53.00 K(-112.1%) | $69.37 M(-0.6%) |
June 2023 | - | $437.00 K(+5.0%) | $69.77 M(+0.1%) |
Mar 2023 | - | $416.00 K(-99.4%) | $69.68 M(-0.4%) |
Dec 2022 | $69.96 M(+2619.1%) | $68.57 M(>+9900.0%) | $69.96 M(-208.8%) |
Sept 2022 | - | $354.00 K(+1.7%) | -$64.30 M(+63.8%) |
June 2022 | - | $348.00 K(-49.9%) | -$39.25 M(+136.5%) |
Mar 2022 | - | $695.00 K(-101.1%) | -$16.60 M(-745.1%) |
Dec 2021 | $2.57 M(-96.0%) | -$65.70 M(-358.6%) | $2.57 M(-97.2%) |
Sept 2021 | - | $25.41 M(+10.5%) | $90.85 M(+7.2%) |
June 2021 | - | $23.00 M(+15.8%) | $84.79 M(+17.0%) |
Mar 2021 | - | $19.87 M(-12.0%) | $72.49 M(+11.7%) |
Dec 2020 | $64.87 M(+30.7%) | $22.58 M(+16.7%) | $64.87 M(+11.5%) |
Sept 2020 | - | $19.34 M(+80.7%) | $58.20 M(-7.0%) |
June 2020 | - | $10.70 M(-12.7%) | $62.57 M(+8.0%) |
Mar 2020 | - | $12.25 M(-23.0%) | $57.95 M(+16.7%) |
Dec 2019 | $49.65 M(+208.4%) | $15.90 M(-33.0%) | $49.65 M(+27.8%) |
Sept 2019 | - | $23.72 M(+290.2%) | $38.83 M(+108.9%) |
June 2019 | - | $6.08 M(+54.0%) | $18.59 M(+14.2%) |
Mar 2019 | - | $3.95 M(-22.5%) | $16.27 M(+1.1%) |
Dec 2018 | $16.10 M(-4.0%) | $5.09 M(+46.5%) | $16.10 M(+6.4%) |
Sept 2018 | - | $3.47 M(-7.7%) | $15.13 M(-5.9%) |
June 2018 | - | $3.76 M(-0.3%) | $16.08 M(-2.9%) |
Mar 2018 | - | $3.77 M(-8.5%) | $16.57 M(-1.3%) |
Dec 2017 | $16.78 M(-13.3%) | $4.12 M(-6.6%) | $16.78 M(-2.1%) |
Sept 2017 | - | $4.42 M(+3.9%) | $17.14 M(-6.1%) |
June 2017 | - | $4.25 M(+6.6%) | $18.26 M(-0.8%) |
Mar 2017 | - | $3.99 M(-11.2%) | $18.41 M(-4.9%) |
Dec 2016 | $19.36 M(-3.9%) | $4.49 M(-18.9%) | $19.36 M(-5.6%) |
Sept 2016 | - | $5.54 M(+25.7%) | $20.50 M(+1.7%) |
June 2016 | - | $4.40 M(-10.7%) | $20.15 M(-2.2%) |
Mar 2016 | - | $4.93 M(-12.4%) | $20.60 M(+2.3%) |
Dec 2015 | $20.14 M(+34.1%) | $5.63 M(+8.5%) | $20.14 M(+7.3%) |
Sept 2015 | - | $5.19 M(+7.1%) | $18.77 M(+5.7%) |
June 2015 | - | $4.85 M(+8.3%) | $17.77 M(+6.6%) |
Mar 2015 | - | $4.47 M(+5.1%) | $16.67 M(+10.9%) |
Dec 2014 | $15.03 M(+71.2%) | $4.26 M(+1.7%) | $15.03 M(+10.2%) |
Sept 2014 | - | $4.19 M(+11.6%) | $13.63 M(+16.1%) |
June 2014 | - | $3.75 M(+32.5%) | $11.74 M(+16.6%) |
Mar 2014 | - | $2.83 M(-1.1%) | $10.07 M(+14.7%) |
Dec 2013 | $8.78 M(+129.8%) | $2.86 M(+24.8%) | $8.78 M(+22.7%) |
Sept 2013 | - | $2.29 M(+10.3%) | $7.15 M(+21.3%) |
June 2013 | - | $2.08 M(+35.4%) | $5.90 M(+27.2%) |
Mar 2013 | - | $1.54 M(+23.9%) | $4.63 M(+21.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2012 | $3.82 M(+82.8%) | $1.24 M(+19.7%) | $3.82 M(+21.9%) |
Sept 2012 | - | $1.04 M(+26.5%) | $3.13 M(+18.9%) |
June 2012 | - | $819.20 K(+13.5%) | $2.63 M(+13.4%) |
Mar 2012 | - | $721.70 K(+30.2%) | $2.32 M(+11.3%) |
Dec 2011 | $2.09 M(+68.1%) | $554.40 K(+2.7%) | $2.09 M(-24.8%) |
Sept 2011 | - | $539.60 K(+6.2%) | $2.78 M(+24.1%) |
June 2011 | - | $508.30 K(+4.6%) | $2.24 M(+29.4%) |
Mar 2011 | - | $485.90 K(-60.9%) | $1.73 M(+39.1%) |
Dec 2010 | $1.24 M(>+9900.0%) | $1.24 M(>+9900.0%) | $1.24 M(>+9900.0%) |
Dec 2009 | $10.60 K(-98.9%) | $10.60 K(-97.1%) | $10.60 K(-99.1%) |
Sept 2006 | - | $368.40 K(+70.3%) | $1.13 M(+11.2%) |
June 2006 | - | $216.30 K(-7.0%) | $1.02 M(+1.8%) |
Mar 2006 | - | $232.70 K(-26.2%) | $1.00 M(+4.0%) |
Dec 2005 | $968.10 K(+55.7%) | $315.10 K(+23.9%) | $962.50 K(+11.1%) |
Sept 2005 | - | $254.30 K(+28.0%) | $866.40 K(+9.8%) |
June 2005 | - | $198.70 K(+2.2%) | $789.00 K(+8.0%) |
Mar 2005 | - | $194.40 K(-11.2%) | $730.50 K(+9.4%) |
Dec 2004 | $621.90 K(+42.1%) | $219.00 K(+23.8%) | $667.70 K(+16.9%) |
Sept 2004 | - | $176.90 K(+26.2%) | $571.00 K(+17.8%) |
June 2004 | - | $140.20 K(+6.5%) | $484.70 K(+4.0%) |
Mar 2004 | - | $131.60 K(+7.6%) | $466.10 K(+6.5%) |
Dec 2003 | $437.60 K(+52.7%) | $122.30 K(+35.0%) | $437.60 K(+6.1%) |
Sept 2003 | - | $90.60 K(-25.5%) | $412.40 K(+4.0%) |
June 2003 | - | $121.60 K(+17.9%) | $396.50 K(+16.5%) |
Mar 2003 | - | $103.10 K(+6.2%) | $340.40 K(+18.8%) |
Dec 2002 | $286.60 K(-13.8%) | $97.10 K(+30.0%) | $286.60 K(+21.7%) |
Sept 2002 | - | $74.70 K(+14.0%) | $235.50 K(+1.6%) |
June 2002 | - | $65.50 K(+32.9%) | $231.90 K(-10.6%) |
Mar 2002 | - | $49.30 K(+7.2%) | $259.50 K(-22.0%) |
Dec 2001 | $332.60 K(-9.6%) | $46.00 K(-35.3%) | $332.60 K(-20.3%) |
Sept 2001 | - | $71.10 K(-23.6%) | $417.20 K(-4.7%) |
June 2001 | - | $93.10 K(-23.9%) | $437.70 K(+3.7%) |
Mar 2001 | - | $122.40 K(-6.3%) | $422.20 K(+14.7%) |
Dec 2000 | $368.00 K(+71.8%) | $130.60 K(+42.6%) | $368.10 K(+20.3%) |
Sept 2000 | - | $91.60 K(+18.0%) | $306.10 K(+12.3%) |
June 2000 | - | $77.60 K(+13.6%) | $272.60 K(+12.7%) |
Mar 2000 | - | $68.30 K(-0.4%) | $241.90 K(+13.1%) |
Dec 1999 | $214.20 K(+10.4%) | $68.60 K(+18.1%) | $213.80 K(+47.2%) |
Sept 1999 | - | $58.10 K(+23.9%) | $145.20 K(+66.7%) |
June 1999 | - | $46.90 K(+16.7%) | $87.10 K(+116.7%) |
Mar 1999 | - | $40.20 K | $40.20 K |
Dec 1998 | $194.00 K(+0.5%) | - | - |
Dec 1997 | $193.10 K(-11.0%) | - | - |
Dec 1996 | $216.90 K(+10.8%) | - | - |
Dec 1995 | $195.80 K(-0.5%) | - | - |
Dec 1994 | $196.80 K(-2.2%) | - | - |
Dec 1993 | $201.20 K | - | - |
FAQ
- What is TherapeuticsMD annual revenue?
- What is the all time high annual revenue for TherapeuticsMD?
- What is TherapeuticsMD annual revenue year-on-year change?
- What is TherapeuticsMD quarterly revenue?
- What is the all time high quarterly revenue for TherapeuticsMD?
- What is TherapeuticsMD quarterly revenue year-on-year change?
- What is TherapeuticsMD TTM revenue?
- What is the all time high TTM revenue for TherapeuticsMD?
- What is TherapeuticsMD TTM revenue year-on-year change?
What is TherapeuticsMD annual revenue?
The current annual revenue of TXMD is $1.30 M
What is the all time high annual revenue for TherapeuticsMD?
TherapeuticsMD all-time high annual revenue is $69.96 M
What is TherapeuticsMD annual revenue year-on-year change?
Over the past year, TXMD annual revenue has changed by -$68.66 M (-98.14%)
What is TherapeuticsMD quarterly revenue?
The current quarterly revenue of TXMD is $547.00 K
What is the all time high quarterly revenue for TherapeuticsMD?
TherapeuticsMD all-time high quarterly revenue is $68.57 M
What is TherapeuticsMD quarterly revenue year-on-year change?
Over the past year, TXMD quarterly revenue has changed by +$600.00 K (+1132.08%)
What is TherapeuticsMD TTM revenue?
The current TTM revenue of TXMD is $1.60 M
What is the all time high TTM revenue for TherapeuticsMD?
TherapeuticsMD all-time high TTM revenue is $90.85 M
What is TherapeuticsMD TTM revenue year-on-year change?
Over the past year, TXMD TTM revenue has changed by -$67.77 M (-97.70%)